These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts. Janusz K; Del Rey M; Abáigar M; Collado R; Ivars D; Hernández-Sánchez M; Valiente A; Robledo C; Benito R; Díez-Campelo M; Ramos F; Kohlmann A; Cañizo CD; Hernández-Rivas JM Leuk Res; 2017 May; 56():82-87. PubMed ID: 28222336 [TBL] [Abstract][Full Text] [Related]
8. Splicing Factor Mutations in Cancer. Bejar R Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388 [TBL] [Abstract][Full Text] [Related]
9. Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators. Qiu J; Zhou B; Thol F; Zhou Y; Chen L; Shao C; DeBoever C; Hou J; Li H; Chaturvedi A; Ganser A; Bejar R; Zhang DE; Fu XD; Heuser M RNA; 2016 Oct; 22(10):1535-49. PubMed ID: 27492256 [TBL] [Abstract][Full Text] [Related]
11. The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. Chen L; Chen JY; Huang YJ; Gu Y; Qiu J; Qian H; Shao C; Zhang X; Hu J; Li H; He S; Zhou Y; Abdel-Wahab O; Zhang DE; Fu XD Mol Cell; 2018 Feb; 69(3):412-425.e6. PubMed ID: 29395063 [TBL] [Abstract][Full Text] [Related]
12. Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS: A meta-analysis. Wang X; Song X; Yan X Medicine (Baltimore); 2019 May; 98(21):e15743. PubMed ID: 31124956 [TBL] [Abstract][Full Text] [Related]
13. Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring Cheruiyot A; Li S; Nonavinkere Srivatsan S; Ahmed T; Chen Y; Lemacon DS; Li Y; Yang Z; Wadugu BA; Warner WA; Pruett-Miller SM; Obeng EA; Link DC; He D; Xiao F; Wang X; Bailis JM; Walter MJ; You Z Cancer Res; 2021 Sep; 81(17):4499-4513. PubMed ID: 34215620 [TBL] [Abstract][Full Text] [Related]
16. Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatment. Pellagatti A; Boultwood J Adv Biol Regul; 2023 Jan; 87():100920. PubMed ID: 36216757 [TBL] [Abstract][Full Text] [Related]
17. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies. Taylor J; Lee SC Genes Chromosomes Cancer; 2019 Dec; 58(12):889-902. PubMed ID: 31334570 [TBL] [Abstract][Full Text] [Related]
18. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887 [TBL] [Abstract][Full Text] [Related]
19. Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. Huber S; Haferlach T; Meggendorfer M; Hutter S; Hoermann G; Summerer I; Fuhrmann I; Baer C; Kern W; Haferlach C Leukemia; 2023 Feb; 37(2):500-502. PubMed ID: 36463343 [No Abstract] [Full Text] [Related]
20. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations. Lee SC; North K; Kim E; Jang E; Obeng E; Lu SX; Liu B; Inoue D; Yoshimi A; Ki M; Yeo M; Zhang XJ; Kim MK; Cho H; Chung YR; Taylor J; Durham BH; Kim YJ; Pastore A; Monette S; Palacino J; Seiler M; Buonamici S; Smith PG; Ebert BL; Bradley RK; Abdel-Wahab O Cancer Cell; 2018 Aug; 34(2):225-241.e8. PubMed ID: 30107174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]